HealthcarePharmaceuticals & BiotechnologyBiotechnology

Genomic Valley Biotech Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 17 Aug 2026
Showing 10 of 27 filings.
17 Aug 20261 filing
Company UpdateNewspaper Publication

Please find enclosed herewith unaudited financial results for the quarter ended on 30th June, 2026.

Filed 21:21View Source
14 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Genomic Valley Biotech approves standalone unaudited Q1 2026 results for quarter ended June 30, 2026

Standalone results approved

  • Approved standalone unaudited results for quarter ended 30 June 2026.

Limited review report

  • Limited review report from Andros & Co. enclosed with the results.
Filed 15:59View Source
6 Aug 20261 filing
Board Meeting

Genomic Valley Biotech to hold Aug 14, 2026 board meeting to consider standalone Q1 unaudited results

Meeting Details

  • Board meeting on Friday, 14 August 2026 at the company's corporate office.

Key Agenda Items

  • Approve unaudited standalone financial results for quarter ended 30 June 2026.
  • Consider any other matter with permission of the chair.

Other Notes

  • Trading window closed from 1 July 2026 until 48 hours after results for insiders.
Filed 12:56View Source
6 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed for quarter ended June 2026; dematerialised securities listed; certificates mutilated and owner updated.

Dematerialisation processing

  • Dematerialisation requests processed in the quarter ended June 2026 and confirmed to the depositories.
  • Securities dematerialised have been listed on the exchanges where earlier securities are listed.
  • Physical certificates received for dematerialisation were mutilated and cancelled; depositories named as registered owners within 15 days.
Filed 15:17View Source
29 Jun 20261 filing
Insider Trading / SASTClosure of Trading Window

Genomic Valley Biotech Limited: Trading Window Closure Ahead of Q1 2026 Results

Trading Window Closure

  • Trading window closed from 01 July 2026 for the unaudited June 30, 2026 results.
  • Closed until 48 hours after results are announced and generally available.
  • During closure, employees, directors, KMPs and designated persons and their immediate relatives must not trade.
  • Board meeting date to declare unaudited results will be intimated in due course.
Filed 12:14View Source
1 Jun 20261 filing
Company UpdateNewspaper Publication

Please find enclosed herewith audited financial results for the quarter and year ended on 31 March 2026.

Filed 12:06View Source
14 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st March, 2026.

Filed 16:06View Source
3 Apr 20261 filing
Company UpdateGeneral

Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ....

Filed 13:01View Source
24 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window for the quarter and year ending on March 31, 2026.

Filed 15:38View Source
17 Jan 20261 filing
Company UpdateNewspaper Publication

Please find enclosed herewith unaudited financial results for the quarter and nine months ended on 31st December 2025.

Filed 12:14View Source
Showing 10 of 27 filings